These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30540124)

  • 1. Primary malignant tumors of the adrenal glands.
    Almeida MQ; Bezerra-Neto JE; Mendonça BB; Latronico AC; Fragoso MCBV
    Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e756s. PubMed ID: 30540124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
    Strosberg JR
    Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of malignant adrenal tumors.
    Kopf D; Goretzki PE; Lehnert H
    J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
    Hamidi O
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa].
    Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Culine S; Durand X; Mathonnet M; Mirallie E; Soulié M;
    Prog Urol; 2010 Nov; 20 Suppl 4():S310-6. PubMed ID: 21129649
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii131-8. PubMed ID: 22997446
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of adrenocortical carcinoma.
    Strosberg JR; Hammer GD; Doherty GM
    J Natl Compr Canc Netw; 2009 Jul; 7(7):752-8; quiz 759. PubMed ID: 19635227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
    Ann Oncol; 2020 Nov; 31(11):1476-1490. PubMed ID: 32861807
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant adrenal tumors.
    Rescorla FJ
    Semin Pediatr Surg; 2006 Feb; 15(1):48-56. PubMed ID: 16458846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare adrenal tumors in children.
    Mihai R
    Semin Pediatr Surg; 2014 Apr; 23(2):71-5. PubMed ID: 24931351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of adrenal tumors in pregnancy.
    Eschler DC; Kogekar N; Pessah-Pollack R
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):381-97. PubMed ID: 26038207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in the treatment of adrenocortical carcinomas].
    Ducry J; Berthold D; Pralong F
    Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.
    Sharma S; Fishbein L
    Endocr Pract; 2023 Dec; 29(12):999-1006. PubMed ID: 37586639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
    Ichijo T; Ueshiba H; Nawata H; Yanase T
    Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
    Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
    Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
    Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
    Lima JV; Kater CE
    Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
    Meijs AC; Snel M; Corssmit EPM
    Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.